SI2651922T1 - Indoli kot protivirusna sredstva za respiratorni sincicijski virus - Google Patents
Indoli kot protivirusna sredstva za respiratorni sincicijski virusInfo
- Publication number
- SI2651922T1 SI2651922T1 SI201130824A SI201130824A SI2651922T1 SI 2651922 T1 SI2651922 T1 SI 2651922T1 SI 201130824 A SI201130824 A SI 201130824A SI 201130824 A SI201130824 A SI 201130824A SI 2651922 T1 SI2651922 T1 SI 2651922T1
- Authority
- SI
- Slovenia
- Prior art keywords
- indoles
- respiratory syncytial
- antiviral agents
- syncytial virus
- virus antiviral
- Prior art date
Links
- 241000725643 Respiratory syncytial virus Species 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10195468 | 2010-12-16 | ||
| EP11794793.7A EP2651922B1 (en) | 2010-12-16 | 2011-12-16 | Indoles as respiratory syncytial virus antiviral agents |
| PCT/EP2011/073011 WO2012080447A1 (en) | 2010-12-16 | 2011-12-16 | Indoles as respiratory syncytial virus antiviral agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2651922T1 true SI2651922T1 (sl) | 2016-08-31 |
Family
ID=43875270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201130824A SI2651922T1 (sl) | 2010-12-16 | 2011-12-16 | Indoli kot protivirusna sredstva za respiratorni sincicijski virus |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US8921560B2 (enExample) |
| EP (1) | EP2651922B1 (enExample) |
| JP (2) | JP5945278B2 (enExample) |
| KR (1) | KR101914606B1 (enExample) |
| CN (1) | CN103347875B (enExample) |
| AR (1) | AR084335A1 (enExample) |
| AU (1) | AU2011343256C1 (enExample) |
| BR (1) | BR112013011949B1 (enExample) |
| CA (1) | CA2822000C (enExample) |
| CL (1) | CL2013001715A1 (enExample) |
| CY (1) | CY1117763T1 (enExample) |
| DK (1) | DK2651922T3 (enExample) |
| EA (1) | EA022339B1 (enExample) |
| ES (1) | ES2572258T3 (enExample) |
| HR (1) | HRP20160533T1 (enExample) |
| HU (1) | HUE028009T2 (enExample) |
| IL (1) | IL225641A (enExample) |
| ME (1) | ME02406B (enExample) |
| MX (1) | MX339944B (enExample) |
| MY (1) | MY163981A (enExample) |
| NZ (1) | NZ609487A (enExample) |
| PH (1) | PH12013500797A1 (enExample) |
| PL (1) | PL2651922T3 (enExample) |
| RS (1) | RS54746B1 (enExample) |
| SG (1) | SG189866A1 (enExample) |
| SI (1) | SI2651922T1 (enExample) |
| SM (1) | SMT201600142B (enExample) |
| TW (1) | TWI515187B (enExample) |
| UA (1) | UA109792C2 (enExample) |
| WO (1) | WO2012080447A1 (enExample) |
| ZA (1) | ZA201304423B (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI527814B (zh) * | 2010-12-16 | 2016-04-01 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類 |
| TWI515187B (zh) | 2010-12-16 | 2016-01-01 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之吲哚類 |
| TWI530495B (zh) | 2010-12-16 | 2016-04-21 | 健生科學愛爾蘭無限公司 | 苯并咪唑呼吸道融合病毒抑制劑 |
| TWI501967B (zh) * | 2010-12-16 | 2015-10-01 | Janssen R&D Ireland | 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類 |
| TWI541241B (zh) | 2010-12-16 | 2016-07-11 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類 |
| HUE033848T2 (en) * | 2012-06-15 | 2018-01-29 | Janssen Sciences Ireland Uc | Heterocyclic-Substituted 1,3-Dihydro-2H-Benzimidazol-2-one Derivatives as Air Giant Cell Virus Virus |
| AU2013276521A1 (en) * | 2012-06-15 | 2014-12-04 | Janssen Sciences Ireland Uc | 1,3 -dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents |
| BR112015000392A2 (pt) * | 2012-07-10 | 2017-06-27 | Hoffmann La Roche | novos indazóis para o tratamento e profilaxia da infecção por vírus sincicial respiratório |
| ES2640446T3 (es) | 2012-10-16 | 2017-11-03 | Janssen Sciences Ireland Uc | Compuestos antivíricos para el VSR |
| BR112016003348B1 (pt) | 2013-08-21 | 2023-03-07 | Alios Biopharma, Inc | Compostos antivirais ou sais farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e seus usos |
| TWI671299B (zh) | 2014-04-14 | 2019-09-11 | 愛爾蘭商健生科學愛爾蘭無限公司 | 作為ｒｓｖ抗病毒化合物之螺脲化合物 |
| AU2015301334A1 (en) * | 2014-08-05 | 2017-02-23 | Alios Biopharma, Inc. | Combination therapy for treating a paramyxovirus |
| MA41614A (fr) | 2015-02-25 | 2018-01-02 | Alios Biopharma Inc | Composés antiviraux |
| MX2017011778A (es) | 2015-03-13 | 2017-12-04 | Forma Therapeutics Inc | Compuestos y composiciones de alfa-cinamida como inhibidores de histona desacetilasa 8 (hdac8). |
| RU2738232C2 (ru) | 2015-07-22 | 2020-12-09 | Энанта Фармасьютикалс, Инк. | Производные бензодиазепина как ингибиторы rsv |
| KR102708936B1 (ko) | 2015-11-20 | 2024-09-25 | 포르마 세라퓨틱스 인크. | 유비퀴틴-특이적 프로테아제 1 억제제로서의 퓨리논 |
| EP3402799B1 (en) | 2016-01-15 | 2022-05-04 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
| KR20180108598A (ko) * | 2016-02-03 | 2018-10-04 | 얀센 사이언시즈 아일랜드 유씨 | Rsv의 치료를 위한 조합 생성물 |
| ES2775782T3 (es) | 2016-03-15 | 2020-07-28 | Bayer Cropscience Ag | Sulfonilamidas sustituidas para combatir parásitos animales |
| TW201822637A (zh) | 2016-11-07 | 2018-07-01 | 德商拜耳廠股份有限公司 | 用於控制動物害蟲的經取代磺醯胺類 |
| MX379326B (es) | 2017-02-16 | 2025-03-11 | Enanta Pharm Inc | Procesos para la preparación de derivados de benzodiazepina |
| WO2019006295A1 (en) | 2017-06-30 | 2019-01-03 | Enanta Pharmaceuticals, Inc. | HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS |
| AU2018339068B2 (en) | 2017-09-29 | 2022-12-15 | Enanta Pharmaceuticals, Inc. | Combination pharmaceutical agents as RSV inhibitors |
| CN111343990B (zh) | 2017-11-13 | 2023-08-04 | 英安塔制药有限公司 | 苯并二氮杂䓬-2-酮和苯并氮杂䓬-2-酮衍生物的拆分方法 |
| TW201936193A (zh) * | 2017-12-05 | 2019-09-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 使用組合產品治療ｒｓｖ |
| PH12021552201A1 (en) | 2019-03-18 | 2022-05-30 | Enanta Pharm Inc | Benzodiazepine derivatives as rsv inhibitors |
| TWI864048B (zh) | 2019-10-04 | 2024-12-01 | 美商安塔製藥公司 | 抗病毒雜環化合物、其醫藥組成物及其用途 |
| US11505558B1 (en) | 2019-10-04 | 2022-11-22 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
| WO2021083998A1 (en) * | 2019-10-30 | 2021-05-06 | Janssen Sciences Ireland Unlimited Company | Synthesis of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2 yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one |
| JP2023500213A (ja) * | 2019-10-30 | 2023-01-05 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | ３－ニトロ－ｎ－（２，２，２－トリフルオロエチル）－４－ピリジンアミンの合成 |
| KR20220098170A (ko) | 2019-11-07 | 2022-07-11 | 바이엘 악티엔게젤샤프트 | 동물 해충 방제를 위한 치환된 술포닐 아미드 |
| UY39032A (es) | 2020-01-24 | 2021-07-30 | Enanta Pharm Inc | Compuestos heterocíclicos como agentes antivirales |
| CN115776982A (zh) * | 2020-06-11 | 2023-03-10 | 爱尔兰詹森科学公司 | 半(L)-酒石酸盐形式的3-({5-氯-1-[3-(甲基磺酰基)丙基]-1H-吲哚-2-基}甲基)-1-(2,2,2-三氟乙基)-1,3-二氢-2H-咪唑并[4,5-c]吡啶-2-酮和包含其的药物组合物 |
| US11534439B2 (en) | 2020-07-07 | 2022-12-27 | Enanta Pharmaceuticals, Inc. | Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors |
| WO2022086840A1 (en) | 2020-10-19 | 2022-04-28 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as anti-viral agents |
| JP2024507561A (ja) | 2021-02-26 | 2024-02-20 | エナンタ ファーマシューティカルズ インコーポレイテッド | 抗ウイルス複素環式化合物 |
| WO2022184606A1 (en) | 2021-03-01 | 2022-09-09 | Janssen Sciences Ireland Unlimited Company | Synthesis of rilematovir |
| CN114014856B (zh) * | 2021-11-26 | 2023-12-22 | 嘉兴安谛康生物科技有限公司 | 作为呼吸道合胞病毒抗病毒剂的咪唑并吡啶类衍生物 |
| AR129003A1 (es) | 2022-04-07 | 2024-07-03 | Enanta Pharm Inc | Compuestos heterocíclicos antivirales |
| WO2023211997A1 (en) | 2022-04-27 | 2023-11-02 | Enanta Pharmaceuticals, Inc. | Antiviral compounds |
| WO2024174953A1 (zh) * | 2023-02-21 | 2024-08-29 | 苏州隆博泰药业有限公司 | 苯并咪唑类衍生物及其医药用途 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ333696A (en) | 1996-07-08 | 2000-06-23 | Du Pont Pharm Co | Amidinoindoles, amidinoazoles, and analogs thereof as inhibitors of trypsin like protease enzymes like thrombin and Xa factor |
| WO2000020400A1 (en) | 1998-10-05 | 2000-04-13 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions for treating hepatitis c infections |
| CZ20012006A3 (cs) | 1998-12-18 | 2002-03-13 | Axys Pharmaceuticals, Inc. | Sloučenina a farmaceutický prostředek |
| WO2001000612A2 (en) | 1999-06-28 | 2001-01-04 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
| AP1552A (en) | 1999-06-28 | 2006-01-17 | Janssen Pharmaceutica Nv | Respiratory syncytial virus replication inhibitors. |
| US6534535B1 (en) * | 1999-08-12 | 2003-03-18 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| US20020019395A1 (en) * | 2000-02-01 | 2002-02-14 | Bing-Yan Zhu | Indalone and benzimidazolone inhibitors of factor Xa |
| US20020072530A1 (en) * | 2000-02-01 | 2002-06-13 | Bing-Yan Zhu | Indole and benzimidazole inhibitors of factor Xa |
| US6489338B2 (en) * | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
| US6506738B1 (en) * | 2000-09-27 | 2003-01-14 | Bristol-Myers Squibb Company | Benzimidazolone antiviral agents |
| US6919331B2 (en) * | 2001-12-10 | 2005-07-19 | Bristol-Myers Squibb Company | Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| HUP0402535A2 (hu) | 2001-12-10 | 2005-04-28 | Bristol-Myers Squibb Co. | RSV fúzió inhibitor hatású imidazo-piridin-vegyület dihidroklorid-monohidrát sója és az ezt tartalmazó gyógyszerkészítmények |
| US20030180957A1 (en) | 2001-12-21 | 2003-09-25 | Sense Proteomic Limited | Target and method |
| AU2003294249A1 (en) | 2002-11-08 | 2004-06-03 | Trimeris, Inc. | Hetero-substituted benzimidazole compounds and antiviral uses thereof |
| AR043692A1 (es) | 2003-02-06 | 2005-08-10 | Novartis Ag | 2-cianopirrolopirimidinas y sus usos farmaceuticos |
| US7343930B2 (en) | 2004-12-03 | 2008-03-18 | Masco Corporation Of Indiana | Sprayer with non-faucet control |
| MY140748A (en) * | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| US9150556B2 (en) | 2007-05-22 | 2015-10-06 | Boehringer Ingelheim International Gmbh | Benzimidazolone chymase inhibitors |
| FR2926556B1 (fr) | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique |
| TWI541241B (zh) * | 2010-12-16 | 2016-07-11 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類 |
| TWI501967B (zh) * | 2010-12-16 | 2015-10-01 | Janssen R&D Ireland | 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類 |
| TWI515187B (zh) | 2010-12-16 | 2016-01-01 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之吲哚類 |
| TWI530495B (zh) * | 2010-12-16 | 2016-04-21 | 健生科學愛爾蘭無限公司 | 苯并咪唑呼吸道融合病毒抑制劑 |
| TWI527814B (zh) * | 2010-12-16 | 2016-04-01 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類 |
| WO2012080481A1 (en) | 2010-12-17 | 2012-06-21 | Sanofi-Aventis Deutschland Gmbh | Medicament administration |
| US20150166533A1 (en) | 2012-06-15 | 2015-06-18 | Janssen R&D Ireland | Novel 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents |
| AU2013276521A1 (en) | 2012-06-15 | 2014-12-04 | Janssen Sciences Ireland Uc | 1,3 -dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents |
| HUE033848T2 (en) | 2012-06-15 | 2018-01-29 | Janssen Sciences Ireland Uc | Heterocyclic-Substituted 1,3-Dihydro-2H-Benzimidazol-2-one Derivatives as Air Giant Cell Virus Virus |
| EP2864299A1 (en) | 2012-06-15 | 2015-04-29 | Janssen Sciences Ireland UC | 4 - substituted 1, 3 - dihydro - 2h - benzimidazol - 2 - one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents |
| ES2640446T3 (es) | 2012-10-16 | 2017-11-03 | Janssen Sciences Ireland Uc | Compuestos antivíricos para el VSR |
-
2011
- 2011-12-15 TW TW100146391A patent/TWI515187B/zh not_active IP Right Cessation
- 2011-12-16 CN CN201180060358.8A patent/CN103347875B/zh not_active Expired - Fee Related
- 2011-12-16 KR KR1020137016980A patent/KR101914606B1/ko not_active Expired - Fee Related
- 2011-12-16 AR ARP110104740A patent/AR084335A1/es active IP Right Grant
- 2011-12-16 AU AU2011343256A patent/AU2011343256C1/en not_active Ceased
- 2011-12-16 SI SI201130824A patent/SI2651922T1/sl unknown
- 2011-12-16 JP JP2013543801A patent/JP5945278B2/ja active Active
- 2011-12-16 SG SG2013026729A patent/SG189866A1/en unknown
- 2011-12-16 BR BR112013011949-7A patent/BR112013011949B1/pt not_active IP Right Cessation
- 2011-12-16 UA UAA201304193A patent/UA109792C2/ru unknown
- 2011-12-16 HU HUE11794793A patent/HUE028009T2/en unknown
- 2011-12-16 MX MX2013006887A patent/MX339944B/es active IP Right Grant
- 2011-12-16 ME MEP-2016-97A patent/ME02406B/me unknown
- 2011-12-16 PL PL11794793.7T patent/PL2651922T3/pl unknown
- 2011-12-16 WO PCT/EP2011/073011 patent/WO2012080447A1/en not_active Ceased
- 2011-12-16 EP EP11794793.7A patent/EP2651922B1/en active Active
- 2011-12-16 US US13/993,200 patent/US8921560B2/en active Active
- 2011-12-16 HR HRP20160533TT patent/HRP20160533T1/hr unknown
- 2011-12-16 MY MYPI2013001279A patent/MY163981A/en unknown
- 2011-12-16 CA CA2822000A patent/CA2822000C/en active Active
- 2011-12-16 DK DK11794793.7T patent/DK2651922T3/en active
- 2011-12-16 EA EA201390883A patent/EA022339B1/ru unknown
- 2011-12-16 ES ES11794793T patent/ES2572258T3/es active Active
- 2011-12-16 RS RS20160332A patent/RS54746B1/sr unknown
- 2011-12-16 PH PH1/2013/500797A patent/PH12013500797A1/en unknown
- 2011-12-16 NZ NZ609487A patent/NZ609487A/en not_active IP Right Cessation
-
2013
- 2013-04-09 IL IL225641A patent/IL225641A/en active IP Right Grant
- 2013-06-13 CL CL2013001715A patent/CL2013001715A1/es unknown
- 2013-06-14 ZA ZA2013/04423A patent/ZA201304423B/en unknown
-
2014
- 2014-11-18 US US14/546,289 patent/US9321768B2/en active Active
-
2016
- 2016-03-11 JP JP2016048038A patent/JP2016145236A/ja active Pending
- 2016-04-22 US US15/136,769 patent/US9944638B2/en active Active
- 2016-05-20 SM SM201600142T patent/SMT201600142B/it unknown
- 2016-05-24 CY CY20161100449T patent/CY1117763T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201304423B (en) | Indoles as respiratory syncytial virus antiviral agents | |
| ZA201304424B (en) | Benzimidazole respiratory syncytial virus inhibitors | |
| AU336564S (en) | Respiratory mask | |
| IL226346A0 (en) | Antiviral compounds | |
| EP2611489A4 (en) | MASK SYSTEM | |
| EP2580190A4 (en) | NEW ANTIVIRAL COMPOUNDS | |
| AU335362S (en) | Mist Sprayer | |
| GB2490507B (en) | Respiratory mask | |
| GB201020496D0 (en) | Improvements relating to breathing systems | |
| ZA201303400B (en) | Rescure descender system | |
| AU335361S (en) | Mist sprayer | |
| PT2613793E (pt) | Spray nasal | |
| EP2638210A4 (en) | SCAFFOLDING FIXATION ASSEMBLY | |
| EP2585073A4 (en) | ANTIVIRAL COMPOUNDS | |
| IL230142A (en) | Connecting strap | |
| AU340029S (en) | Respiratory mask | |
| EP2664621A4 (en) | virucidal | |
| GB2482320B (en) | Headgear-mountable respirator | |
| EP2782585A4 (en) | ANTIVIRAL PREPARATIONS | |
| GB2524676B (en) | Headgear-mountable respirator | |
| TWM385968U (en) | Tightly-attached mask | |
| GB201013720D0 (en) | Droplet generator | |
| GB201021160D0 (en) | Mask | |
| GB201010777D0 (en) | Quick fit loft aerial bracket | |
| AU333206S (en) | Respirator |